应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MOR Morphosys AG
交易中 12-23 09:48:44 EST
18.96
+0.00
0.00%
最高
18.96
最低
18.96
成交量
0.00
今开
18.96
昨收
18.96
日振幅
0.00%
总市值
28.56亿
流通市值
1,715万
总股本
1.51亿
成交额
0.00
换手率
0.00%
流通股本
90.45万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
MorphoSys任命诺华高管为新任CEO和CFO
财通社 · 06-07
MorphoSys任命诺华高管为新任CEO和CFO
SK海力士计划在第6代(1c工艺 约10nm)DRAM的生产中使用Inpria下一代金属氧化物光刻胶(MOR),这是MOR首次应用于DRAM量产工艺。
华尔街见闻 · 05-30
SK海力士计划在第6代(1c工艺 约10nm)DRAM的生产中使用Inpria下一代金属氧化物光刻胶(MOR),这是MOR首次应用于DRAM量产工艺。
消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶
IT之家 · 05-30
消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶
【AI 开源激励网络 Morpheus 推出代币 MOR】5月8日消息,Wormhole 宣布 AI 开源激励网络 Morpheus 通过 Wormhole 的原生代币转移(NTT)框架推出多链代币 MOR,该代币将奖励共同构建、维护和利用开源去中心化人工智能基础设施的贡献者。
金色财经 · 05-08
【AI 开源激励网络 Morpheus 推出代币 MOR】5月8日消息,Wormhole 宣布 AI 开源激励网络 Morpheus 通过 Wormhole 的原生代币转移(NTT)框架推出多链代币 MOR,该代币将奖励共同构建、维护和利用开源去中心化人工智能基础设施的贡献者。
Morphosys2024财年第一财季实现净利润-3.38亿美元,同比减少609.04%
自选股智能写手 · 05-04
Morphosys2024财年第一财季实现净利润-3.38亿美元,同比减少609.04%
大公司日报|万科再发声,管理层将增持!郁亮:股价距要求很远
腾讯自选股 · 04-30
大公司日报|万科再发声,管理层将增持!郁亮:股价距要求很远
【消息称三星计划量产的1c DRAM使用MOR光刻胶】金十数据4月30日讯,三星正在考虑在其下一代DRAM极紫外(EUV)光刻工艺中应用金属氧化物抗蚀剂(MOR)。
美港电讯 · 04-30
【消息称三星计划量产的1c DRAM使用MOR光刻胶】金十数据4月30日讯,三星正在考虑在其下一代DRAM极紫外(EUV)光刻工艺中应用金属氧化物抗蚀剂(MOR)。
Morphosys盘中异动 股价大跌5.02%
自选股智能写手 · 04-30
Morphosys盘中异动 股价大跌5.02%
受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
智通财经 · 04-29
受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
【受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行】智通财经APP获悉,周一,德国生物技术公司Morphosys(MOR.
智通财经 · 04-29
【受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行】智通财经APP获悉,周一,德国生物技术公司Morphosys(MOR.
【诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股】智通财经APP获悉,诺华制药(NVS.
智通财经 · 04-11
【诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股】智通财经APP获悉,诺华制药(NVS.
诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股
智通财经网 · 04-11
诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股
公司概况
公司名称:
Morphosys AG
所属市场:
NASDAQ
上市日期:
--
主营业务:
MorphoSys AG成立于1998年3月3日,是一家后期生物制药公司,致力于为患有严重疾病的患者开发创新和差异化疗法。基于其在治疗性抗体发现,发电和工程领域的专有技术平台和领先地位,该公司与其合作伙伴一起参与了100多种治疗性产品的开发。他们广泛的管线跨越两个业务部分:专有开发以及合作发现,该公司根据合作伙伴确定的目标为其制药和生物技术行业的合作伙伴生成候选产品。该公司目前在临床开发中有28种产品候选产品,包括最先进的专利产品候选产品MOR208,用于治疗复发或难治性弥漫大B细胞淋巴瘤。
发行价格:
--
{"stockData":{"symbol":"MOR","market":"US","secType":"STK","nameCN":"Morphosys AG","latestPrice":18.96,"timestamp":1734965324466,"preClose":18.96,"halted":0,"volume":0,"delay":0,"floatShares":904508,"shares":150650952,"eps":-3.529278,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-23 09:48:44 EST","open":18.96,"high":18.96,"low":18.96,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.529278,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":1,"listingDate":1524110400000,"adjPreClose":18.96,"adrRate":0.25,"volumeRatio":0,"impliedVol":0.649,"impliedVolPercentile":0.7716},"requestUrl":"/m/hq/s/MOR/wiki","defaultTab":"wiki","newsList":[{"id":"2441838777","title":"MorphoSys任命诺华高管为新任CEO和CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2441838777","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441838777?lang=zh_cn&edition=full","pubTime":"2024-06-07 08:25","pubTimestamp":1717719900,"startTime":"0","endTime":"0","summary":"生物制药公司MorphoSys当地时间6月6日公告称,决定任命ArkadiusPichota为新任首席执行官,Pichota是诺华子公司NavigateBioPharmaServices的总裁;决定任命LukasGilgen为新任首席财务官,Gilgen是诺华公司企业项目的交易负责人。此前在2月,诺华制药宣布将以27亿欧元收购总部位于德国的生物制药公司MorphoSys,将MorphoSys的癌症治疗药物纳入其产品线。(界面)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406070826089f2232aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406070826089f2232aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVS","BK4139","BK4585","LU0211331839.USD","IE0009355771.USD","MOR","BK4578","IE00BJT1NW94.SGD","BK4532","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4007","IE00B2B36J28.USD","BK4588","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2439763140","title":"SK海力士计划在第6代(1c工艺 约10nm)DRAM的生产中使用Inpria下一代金属氧化物光刻胶(MOR),这是MOR首次应用于DRAM量产工艺。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439763140","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439763140?lang=zh_cn&edition=full","pubTime":"2024-05-30 08:43","pubTimestamp":1717029826,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4170","SSNLF","03145","SMSD.UK","BK4139","BK4213","DRAM","PR","MOR","BK5113"],"gpt_icon":0},{"id":"2439544633","title":"消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶","url":"https://stock-news.laohu8.com/highlight/detail?id=2439544633","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439544633?lang=zh_cn&edition=full","pubTime":"2024-05-30 06:57","pubTimestamp":1717023422,"startTime":"0","endTime":"0","summary":"IT之家 5 月 30 日消息,随着 DRAM 小型化的不断推进,SK 海力士、三星电子等公司正在致力于新材料的开发和应用。据 TheElec,SK Hynix 计划在第 6 代DRAM 的生产中使用 Inpria 下一代金属氧化物光刻胶,这是 MOR 首次应用于 DRAM 量产工艺。消息人士称,SK Hynix 量产的 1c DRAM 上有五个极紫外 层,其中一层将使用 MOR 绘制。TheElec 报道还指出,三星电子也在考虑将 MOR 应用于 1c DRAM,目前三星电子在 1c DRAM 上应用了 6 至 7 个 EUV 层,而美光则只应用了 1 层。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8Zz2gm1Esbm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["DRAM","BK4139","MOR"],"gpt_icon":0},{"id":"2433729654","title":"【AI 开源激励网络 Morpheus 推出代币 MOR】5月8日消息,Wormhole 宣布 AI 开源激励网络 Morpheus 通过 Wormhole 的原生代币转移(NTT)框架推出多链代币 MOR,该代币将奖励共同构建、维护和利用开源去中心化人工智能基础设施的贡献者。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729654","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433729654?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:33","pubTimestamp":1715175216,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["MOR","BK4139","161631"],"gpt_icon":0},{"id":"2432183683","title":"Morphosys2024财年第一财季实现净利润-3.38亿美元,同比减少609.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432183683","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432183683?lang=zh_cn&edition=full","pubTime":"2024-05-04 00:27","pubTimestamp":1714753632,"startTime":"0","endTime":"0","summary":"3月31日,Morphosys公布财报,公告显示公司2024财年第一财季净利润为-3.38亿美元,同比减少609.04%;其中营业收入为29.89百万美元,同比减少55.29%,每股基本收益为-2.27美元。从资产负债表来看,Morphosys总负债22.61亿美元,其中短期债务6.27百万美元,资产负债比为0.88,流动比率为1.39。机构评级:截至2024年3月31日,当前有7家机构对Morphosys目标价做出预测,其中目标均价为16.39美元,其中最低目标价为10.80美元,最高目标价为18.51美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040027158b70dc1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040027158b70dc1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOR"],"gpt_icon":0},{"id":"2431124263","title":"大公司日报|万科再发声,管理层将增持!郁亮:股价距要求很远","url":"https://stock-news.laohu8.com/highlight/detail?id=2431124263","media":"腾讯自选股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431124263?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:07","pubTimestamp":1714475268,"startTime":"0","endTime":"0","summary":"管理层将增持,郁亮:股价距自己要求很远2、华为一季度归母净利润约196.5亿元,同比增长约564%3、特斯拉和百度地图独家深度定制车道级高辅地图4、苹果从谷歌挖走多名AI专家1、万科再发声!4月30日,万科董事会主席郁亮在万科2023年度股东大会上首次发言,对万科股价波动问题予以回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301848047a57b751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301848047a57b751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823411888.USD","LU0640798160.USD","LU1571399168.USD","LU1023057109.AUD","LU0109391861.USD","LU2092937221.SGD","LU0061474960.USD","BIDU","GOOG","LU0353189680.USD","IE00B1BXHZ80.USD","LU0528227936.USD","MOR","BK4538","LU1429558221.USD","IE00B3S45H60.SGD","LU0061475181.USD","LU0289960550.SGD","LU0353189763.USD","BK4535","PR","LU0053666078.USD","LU0348723411.USD","TSLA","LU0889565833.HKD","IE00B1XK9C88.USD","CAR","IE00B19Z9505.USD","BK4533","LU0354030511.USD","GOOGL","LU0965509283.SGD","LU0256863811.USD","IE00BFSS8Q28.SGD","LU0354030438.USD","IE00B7KXQ091.USD","LU1435385759.SGD","BK4531","AAPL","A","LU0823414478.USD","LU0211327993.USD","LU1280957306.USD","LU0082616367.USD","LU0130102774.USD","LU0316494557.USD","LU0128525929.USD","BK4532","LU1814569148.SGD","BK4534","LU0251142724.SGD"],"gpt_icon":0},{"id":"2431142359","title":"【消息称三星计划量产的1c DRAM使用MOR光刻胶】金十数据4月30日讯,三星正在考虑在其下一代DRAM极紫外(EUV)光刻工艺中应用金属氧化物抗蚀剂(MOR)。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431142359","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431142359?lang=zh_cn&edition=full","pubTime":"2024-04-30 14:08","pubTimestamp":1714457305,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["DRAM","BK4139","BK4213","BK5113","MOR","SG9999004220.SGD","PR","BK4230","SMSN.UK","CAR","BK4022","159813","LU0868486357.SGD","LU0431992006.USD"],"gpt_icon":0},{"id":"2431947817","title":"Morphosys盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431947817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431947817?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:53","pubTimestamp":1714413225,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时53分,Morphosys股票出现异动,股价急速下挫5.02%。Morphosys股票所在的生物技术行业中,整体涨幅为0.79%。消息层面,截至01时53分,《受药物安全问题报道冲击,Morphosys称诺华制药收购仍将按计划进行》资讯为影响Morphosys的重要信息。截至发稿,Morphosys美股盘前下跌2.38%,诺华制药美股盘前上涨了0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300153457a574f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300153457a574f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOR","BK4139"],"gpt_icon":0},{"id":"2431594928","title":"受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2431594928","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431594928?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:21","pubTimestamp":1714393287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一,德国生物技术公司Morphosys股价下滑,受到一则关于其药物或具有安全风险的新闻报道影响,但Morphosys表示,诺华制药对其收购仍有望在今年上半年完成。Pelabresib被视为Morphosys公司最有前途的药物之一,也是诺华制药对该公司感兴趣的原因之一。Morphosys发言人补充道:“诺华的收购计划正在稳步推进。”诺华制药于今年2月达成协议,将以27亿欧元的价格收购Morphosys公司。截至发稿,Morphosys美股盘前下跌2.38%,诺华制药美股盘前上涨了0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4139","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","01477","BK1574","BK4578","IE00BJT1NW94.SGD","IE0002141913.USD","LU0211331839.USD","BK4007","NVS","BK1191","BK4532","IE0009355771.USD","MOR","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2431594508","title":"【受药物安全问题报道冲击,Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行】智通财经APP获悉,周一,德国生物技术公司Morphosys(MOR.","url":"https://stock-news.laohu8.com/highlight/detail?id=2431594508","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431594508?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:21","pubTimestamp":1714393287,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002141913.USD","BK4139","BK4585","BK4007","BK4532","IE0009355771.USD","BK4588","BK1574","01477","LU0211331839.USD","NVS","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4578","IE00B2B36J28.USD","BK1191","MOR"],"gpt_icon":0},{"id":"2426582253","title":"【诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股】智通财经APP获悉,诺华制药(NVS.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426582253","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426582253?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:32","pubTimestamp":1712835152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","BK4139","IE00BFTCPJ56.SGD","BK4578","EURmain","LU0211331839.USD","NVS","IE0002141913.USD","MOR","01477","FXE","MEURmain","BK4588","BK1191","IE00BJT1NW94.SGD","BK4007","EUO","BK4532","IE00B2B36J28.USD","BK1574","BK4585","IE0009355771.USD"],"gpt_icon":0},{"id":"2426253531","title":"诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约 收购价68欧元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426253531","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426253531?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:32","pubTimestamp":1712835152,"startTime":"0","endTime":"0","summary":"诺华制药已经对德国癌症制药商MorphoSys发起了收购要约,拟以每股68欧元或总计27亿欧元的现金收购该公司所有已发行股票。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20240411/20240411193309_72568.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240411/20240411193309_72568.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4532","BK4007","BK4585","01477","IE0009355771.USD","BK1574","BK4139","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","MOR","IE00B2B36J28.USD","BK1191","BK4578","NVS","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.morphosys.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0418},{"period":"1year","weight":1.095},{"period":"ytd","weight":0.9152}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MorphoSys AG成立于1998年3月3日,是一家后期生物制药公司,致力于为患有严重疾病的患者开发创新和差异化疗法。基于其在治疗性抗体发现,发电和工程领域的专有技术平台和领先地位,该公司与其合作伙伴一起参与了100多种治疗性产品的开发。他们广泛的管线跨越两个业务部分:专有开发以及合作发现,该公司根据合作伙伴确定的目标为其制药和生物技术行业的合作伙伴生成候选产品。该公司目前在临床开发中有28种产品候选产品,包括最先进的专利产品候选产品MOR208,用于治疗复发或难治性弥漫大B细胞淋巴瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.045203},{"month":2,"riseRate":0.166667,"avgChangeRate":0.01596},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.06954},{"month":4,"riseRate":0.666667,"avgChangeRate":0.051271},{"month":5,"riseRate":0.714286,"avgChangeRate":0.070026},{"month":6,"riseRate":0.428571,"avgChangeRate":0.002422},{"month":7,"riseRate":0.714286,"avgChangeRate":0.030643},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.03697},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.045532},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.02891},{"month":11,"riseRate":0.428571,"avgChangeRate":0.012484},{"month":12,"riseRate":0.428571,"avgChangeRate":0.040986}],"exchange":"NASDAQ","name":"Morphosys AG","nameEN":"Morphosys AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Morphosys AG(MOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Morphosys AG(MOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Morphosys AG,MOR,Morphosys AG股票,Morphosys AG股票老虎,Morphosys AG股票老虎国际,Morphosys AG行情,Morphosys AG股票行情,Morphosys AG股价,Morphosys AG股市,Morphosys AG股票价格,Morphosys AG股票交易,Morphosys AG股票购买,Morphosys AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Morphosys AG(MOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Morphosys AG(MOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}